Home/Filings/4/0001209191-24-001905
4//SEC Filing

Shetzline Michael 4

Accession 0001209191-24-001905

CIK 0001446847other

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 4:05 PM ET

Size

4.9 KB

Accession

0001209191-24-001905

Insider Transaction Report

Form 4
Period: 2024-01-17
Shetzline Michael
SVP, CMO, Head-Res&Drug
Transactions
  • Award

    Class A Common Stock

    2024-01-17+57,971379,102 total
Footnotes (1)
  • [F1]Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted March 26, 2021. The earned PSUs were certified and vested on January 17, 2024.

Issuer

IRONWOOD PHARMACEUTICALS INC

CIK 0001446847

Entity typeother

Related Parties

1
  • filerCIK 0001808509

Filing Metadata

Form type
4
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 4:05 PM ET
Size
4.9 KB